Pacira Biosciences, Inc. (PCRX)
36.38
+0.04
(+0.11%)
USD |
NASDAQ |
Oct 20, 16:00
36.50
+0.12
(+0.33%)
After-Hours: 06:50
Pacira Biosciences Research and Development Expense (TTM) : 121.73M for June 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 121.73M |
| March 31, 2026 | 119.69M |
| December 31, 2025 | 116.96M |
| September 30, 2025 | 103.40M |
| June 30, 2025 | 96.54M |
| March 31, 2025 | 88.68M |
| December 31, 2024 | 81.58M |
| September 30, 2024 | 77.14M |
| June 30, 2024 | 78.87M |
| March 31, 2024 | 77.36M |
| December 31, 2023 | 76.26M |
| September 30, 2023 | 74.30M |
| June 30, 2023 | 72.87M |
| March 31, 2023 | 80.33M |
| December 31, 2022 | 84.80M |
| September 30, 2022 | 82.81M |
| June 30, 2022 | 74.98M |
| March 31, 2022 | 61.27M |
| December 31, 2021 | 55.54M |
| September 30, 2021 | 55.36M |
| June 30, 2021 | 58.43M |
| March 31, 2021 | 59.48M |
| December 31, 2020 | 59.42M |
| September 30, 2020 | 63.74M |
| June 30, 2020 | 69.35M |
| Date | Value |
|---|---|
| March 31, 2020 | 73.55M |
| December 31, 2019 | 72.12M |
| September 30, 2019 | 66.64M |
| June 30, 2019 | 61.28M |
| March 31, 2019 | 55.69M |
| December 31, 2018 | 55.69M |
| September 30, 2018 | 51.54M |
| June 30, 2018 | 48.42M |
| March 31, 2018 | 55.04M |
| December 31, 2017 | 57.29M |
| September 30, 2017 | 64.33M |
| June 30, 2017 | 62.31M |
| March 31, 2017 | 52.82M |
| December 31, 2016 | 45.68M |
| September 30, 2016 | 41.76M |
| June 30, 2016 | 37.90M |
| March 31, 2016 | 32.19M |
| December 31, 2015 | 28.66M |
| September 30, 2015 | 19.40M |
| June 30, 2015 | 17.93M |
| March 31, 2015 | 19.49M |
| December 31, 2014 | 18.73M |
| September 30, 2014 | 19.68M |
| June 30, 2014 | 21.22M |
| March 31, 2014 | 20.86M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Viatris, Inc. | 995.00M |
| Johnson & Johnson | 16.02B |
| Liquidia Corp. | 54.95M |
| Organon & Co. | 358.00M |
| ANI Pharmaceuticals, Inc. | 49.91M |